Request for Trading Halt::Request for Trading Halt

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Note: In line with current market practice, trading on SGX-ST of all securities related to the counter(s) have also been similarly halted.
Stapled Security
No

Announcement Details

Announcement Title
Request for Trading Halt
Date &Time of Broadcast
11-Feb-2022 12:55:55
Status
New
Announcement Sub Title
Request for Trading Halt
Announcement Reference
SG220211OTHRJ0U4
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Effective Date and Time of the event
With Immediate Effect
Reasons for Trading Halt
Temporary trading halt following the release of results announcement to allow for 30 minutes dissemination time.

This announcement has been prepared by iX Biopharma Ltd. (the Company ) and its contents have been reviewed by the Company s Sponsor, UOB Kay Hian Private Limited (the Sponsor ), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the SGX-ST ) Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Lance Tan, Senior Vice President, at 8 Anthony Road, #01-01, Singapore 229957, telephone: (65) 6590 6881.

DISCLAIMER: This announcement was prepared and issued by the named Issuer/ Manager to the Exchange. The Exchange assumes no responsibility for the correctness of any of the statements made, opinions expressed or reports contained in this announcement and is posting this announcement on SGXNet for the sole purpose of dissemination only. In the event of any queries or clarification required in respect of any matters arising from this announcement, such queries are to be made to the named Issuer/ Manager directly and not to the Exchange. The Exchange shall not be liable for any losses or damages howsoever arising as a result of the circulation, publication and dissemination of this announcement.